{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:49:03Z","timestamp":1781423343203,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012537","name":"Ditmanson Medical Foundation Chia-Yi Christian Hospital","doi-asserted-by":"publisher","award":["NCKUCYC-P-11101"],"award-info":[{"award-number":["NCKUCYC-P-11101"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan","award":["108-2320-B-006-026"],"award-info":[{"award-number":["108-2320-B-006-026"]}]},{"name":"National Science and Technology Council, Taiwan","award":["112-2314-B-006-045"],"award-info":[{"award-number":["112-2314-B-006-045"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Oncolytic adenoviruses have emerged as a promising therapeutic approach for cancer therapy. However, systemic delivery of the viruses to metastatic tumors remains a major challenge. Mesenchymal stem cells (MSCs) possess tumor tropism property and can be used as cellular vehicles for delivering oncolytic adenoviruses to tumor sites. Since telomerase activity is found in ~90% of human carcinomas, but undetected in normal adult cells, the human telomerase reverse transcriptase gene (TERT) promoter can be exploited for regulating the replication of oncolytic adenoviruses. Here, we evaluated the antitumor effects of syngeneic murine MSCs loaded with the luciferase-expressing, telomerase-dependent oncolytic adenovirus Ad.GS2 (MSC-Ad.GS2) and Ad.GS2 alone on metastatic MBT-2 bladder tumors. MSCs supported a low degree of Ad.GS2 replication, which could be augmented by coculture with MBT-2 cells or tumor-conditioned medium (TCM), suggesting that viral replication is increased when MSC-Ad.GS2 migrates to tumor sites. MBT-2 cells and TCM enhanced viral replication in Ad.GS2-infected MSCs. SDF-1 is a stem cell homing factor. Our results suggest that the SDF-1\/STAT3\/TERT signaling axis in MSCs in response to the tumor microenvironment may contribute to the enhanced replication of Ad.GS2 carried by MSCs. Notably, we demonstrate the potent therapeutic efficacy of systemically delivered MSC-Ad.GS2 in pleural disseminated tumor and experimental metastasis models using intrapleural and tail vein injection of MBT-2 cells, respectively. Treatment with MSC-Ad.GS2 significantly reduced tumor growth and prolonged the survival of mice bearing metastatic bladder tumors. Since telomerase is expressed in a broad spectrum of cancers, this therapeutic strategy may be broadly applicable.<\/jats:p>","DOI":"10.1093\/stcltm\/szae039","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:00:42Z","timestamp":1718182842000},"page":"738-749","source":"Crossref","is-referenced-by-count":3,"title":["Syngeneic mesenchymal stem cells loaded with telomerase-dependent oncolytic adenoviruses enhance anti-metastatic efficacy"],"prefix":"10.1093","volume":"13","author":[{"given":"Mei-Lin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital , Chiayi , Taiwan"},{"name":"Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Yuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Che","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Ditmanson Medical Foundation Chia-Yi Christian Hospital , Chiayi , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ching","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ru","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hua","family":"Su","sequence":"additional","affiliation":[{"name":"School of Respiratory Therapy, College of Medicine, Taipei Medical University , Taipei , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Che","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Ditmanson Medical Foundation Chia-Yi Christian Hospital , Chiayi , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Li","family":"Shiau","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital , Chiayi , Taiwan"},{"name":"Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia-Shing","family":"Shieh","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"},{"name":"Department of Urology, Tainan Hospital, Department of Health, Executive Yuan , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-9406","authenticated-orcid":false,"given":"Chao-Liang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital , Chiayi , Taiwan"},{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University , Tainan , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pensee","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medicine, Keele University , Staffordshire , United Kingdom"},{"name":"Department of Obstetrics and Gynaecology, University Hospital of North Midlands , Newcastle-under-Lyme, Staffordshire , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"5286","key":"2024081617213342000_CIT0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"issue":"4","key":"2024081617213342000_CIT0002","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/1078-0432.CCR-07-1047","article-title":"Tumor-selective replication of an oncolytic adenovirus carrying oct-3\/4 response elements in murine metastatic bladder cancer models","volume":"14","author":"Wu","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"15","key":"2024081617213342000_CIT0003","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1158\/0008-5472.CAN-08-0094","article-title":"Oct-3\/4 expression reflects tumor progression and regulates motility of bladder cancer cells","volume":"68","author":"Chang","year":"2008","journal-title":"Cancer Res"},{"issue":"8","key":"2024081617213342000_CIT0004","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cgt.2008.37","article-title":"Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy","volume":"15","author":"Hsu","year":"2008","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"2024081617213342000_CIT0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/gt.2014.122","article-title":"Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer","volume":"22","author":"Lu","year":"2015","journal-title":"Gene Ther"},{"issue":"35","key":"2024081617213342000_CIT0006","doi-asserted-by":"crossref","first-page":"38308","DOI":"10.18632\/oncotarget.5702","article-title":"Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity","volume":"6","author":"Su","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"2024081617213342000_CIT0007","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41585-018-0001-5","article-title":"Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis","volume":"15","author":"G\u00fcnes","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"6225","key":"2024081617213342000_CIT0008","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1260200","article-title":"Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer","volume":"347","author":"Borah","year":"2015","journal-title":"Science"},{"issue":"20","key":"2024081617213342000_CIT0009","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1158\/0008-5472.CAN-06-1138","article-title":"Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model","volume":"66","author":"Shieh","year":"2006","journal-title":"Cancer Res"},{"issue":"22","key":"2024081617213342000_CIT0010","first-page":"7936","article-title":"Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis","volume":"63","author":"Lanson","year":"2003","journal-title":"Cancer Res"},{"issue":"11","key":"2024081617213342000_CIT0011","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1002\/art.24940","article-title":"Amelioration of experimental arthritis by a telomerase-dependent conditionally replicating adenovirus that targets synovial fibroblasts","volume":"60","author":"Chen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5309","key":"2024081617213342000_CIT0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"issue":"5411","key":"2024081617213342000_CIT0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2024081617213342000_CIT0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cytogfr.2024.01.004","article-title":"Signaling crosstalk between mesenchymal stem cells and tumor cells: Implications for tumor suppression or progression","volume":"76","author":"Taheri","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"2024081617213342000_CIT0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/gt.2008.39","article-title":"Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells","volume":"15","author":"Spaeth","year":"2008","journal-title":"Gene Ther"},{"issue":"10","key":"2024081617213342000_CIT0016","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/stem.187","article-title":"Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging","volume":"27","author":"Kidd","year":"2009","journal-title":"Stem Cells"},{"issue":"9","key":"2024081617213342000_CIT0017","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/sctm.18-0024","article-title":"Concise review: mesenchymal stem cell-based drug delivery: the good, the bad, the ugly, and the promise","volume":"7","author":"Krueger","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"2024081617213342000_CIT0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fbioe.2020.00043","article-title":"Therapeutic potential of mesenchymal stem cells for cancer therapy","volume":"8","author":"Hmadcha","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2024081617213342000_CIT0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12964-022-01012-0","article-title":"Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment","volume":"21","author":"Ghasemi Darestani","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2024081617213342000_CIT0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12964-023-01232-y","article-title":"Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery","volume":"21","author":"Ghaleh","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"11","key":"2024081617213342000_CIT0021","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1080\/17425247.2021.1960309","article-title":"Mesenchymal stem\/stromal cells as next-generation drug delivery vehicles for cancer therapeutics","volume":"18","author":"Takayama","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"2024081617213342000_CIT0022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.omto.2022.03.008","article-title":"Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors","volume":"25","author":"Yoon","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"5","key":"2024081617213342000_CIT0023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1634\/stemcells.21-5-527","article-title":"Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method","volume":"21","author":"Sun","year":"2003","journal-title":"Stem Cells"},{"issue":"1","key":"2024081617213342000_CIT0024","first-page":"338","article-title":"Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function","volume":"9","author":"Hsieh","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2024081617213342000_CIT0025","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6600908","article-title":"Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5","volume":"88","author":"Hsieh","year":"2003","journal-title":"Br J Cancer"},{"issue":"5","key":"2024081617213342000_CIT0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/hum.2016.035","article-title":"Gene delivery of calreticulin anti-angiogenic domain attenuates the development of choroidal neovascularization in rats","volume":"28","author":"Bee","year":"2017","journal-title":"Hum Gene Ther"},{"key":"2024081617213342000_CIT0027","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/ncomms2906","article-title":"Prothymosin \u03b1 overexpression contributes to the development of pulmonary emphysema","volume":"4","author":"Su","year":"2013","journal-title":"Nat Commun"},{"issue":"2","key":"2024081617213342000_CIT0028","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1634\/stemcells.2006-0257","article-title":"Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells","volume":"25","author":"Menon","year":"2007","journal-title":"Stem Cells"},{"issue":"4","key":"2024081617213342000_CIT0029","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/stem.23","article-title":"Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium","volume":"27","author":"Gao","year":"2009","journal-title":"Stem Cells"},{"issue":"15","key":"2024081617213342000_CIT0030","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1158\/0008-5472.CAN-05-0924","article-title":"Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells","volume":"65","author":"Konnikova","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2024081617213342000_CIT0031","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ymthe.2020.01.019","article-title":"First-in-human, First-in-child trial of autologous MSCs carrying the oncolytic virus Icovir-5 in patients with advanced tumors","volume":"28","author":"Ruano","year":"2020","journal-title":"Mol Ther"},{"issue":"2","key":"2024081617213342000_CIT0032","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0042-6822(90)90147-J","article-title":"Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis","volume":"179","author":"Yew","year":"1990","journal-title":"Virology"},{"issue":"3","key":"2024081617213342000_CIT0033","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1525-0016(03)00199-0","article-title":"Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy","volume":"8","author":"Halld\u00e9n","year":"2003","journal-title":"Mol Ther"},{"issue":"11","key":"2024081617213342000_CIT0034","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/nbt887","article-title":"E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models","volume":"21","author":"Wang","year":"2003","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2024081617213342000_CIT0035","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1172\/JCI45585","article-title":"Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice","volume":"121","author":"Woller","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2024081617213342000_CIT0036","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/1535-7163.MCT-18-0431","article-title":"Enhanced antitumor efficacy of oncolytic adenovirus-loaded menstrual blood-derived mesenchymal stem cells in combination with peripheral blood mononuclear cells","volume":"18","author":"Moreno","year":"2019","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2024081617213342000_CIT0037","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3171\/2021.3.JNS203045","article-title":"Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma","volume":"136","author":"Shimizu","year":"2022","journal-title":"J Neurosurg"},{"issue":"9","key":"2024081617213342000_CIT0038","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3390\/ijms21093052","article-title":"A comparison of immune responses exerted following syngeneic, allogeneic, and xenogeneic transplantation of mesenchymal stem cells into the mouse brain","volume":"21","author":"Hwang","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2024081617213342000_CIT0039","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1158\/0008-5472.CAN-18-3900","article-title":"Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma","volume":"79","author":"Yoon","year":"2019","journal-title":"Cancer Res"},{"key":"2024081617213342000_CIT0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.omto.2022.01.007","article-title":"Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model","volume":"24","author":"Zhang","year":"2022","journal-title":"Mol Ther Oncolytics"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/13\/8\/738\/58838560\/szae039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/13\/8\/738\/58838560\/szae039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:22:59Z","timestamp":1723828979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/13\/8\/738\/7691481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,6,12]]},"published-print":{"date-parts":[[2024,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szae039","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,6,12]]}}}